Moderator: Manuel A. Espinoza, MD, MSc, PhD, Professor, Department of Public Health & Chief, Unit of Health Technology Assessment - Center for Clinical Research, Catholic University of Chile, Santiago, Chile
Panelists: Samanta Anriquez, MD MSc Public Health Specialist, Public Health, Pontificia Universidad Catolica de Chile, SANTIAGO, Chile; Paula Zamorano, PT MHA, Project Manager, Health Innovation Center, SANTIAGO, Chile; Ramon Castaño, MD MSc PhD, Consultant, Organization for Excellence in Health, Colombia, Bogotá, Colombia
ISSUE: As populations become older, Multimorbidity (MM), the coexistence of 2 or more chronic conditions, has been positioned as one of the main challenges for health systems. However, in LA, MM is yet an unknown phenomenon, due to the lack of measurement as well as the absence of, an effective and value based, care model. In the world, several approaches are being made regarding MM. Thus, multimorbidity itself is being used as a risk stratification measurement to tailor clinical care and, also, to allocate financial resources in a risk adjusted manner. It is urgent for LA health services to get on board with this challenging issue.
OVERVIEW: This panel will discuss about the state of knowledge of MM in Latin America, as well as its burden in health services. It will focus on value- based care model using population risk stratification. It is addressed to decision makers as well as clinicians. Dr. Espinoza will moderate and expose the prevalence of MM in Chile and will expand on the capacity for the Chilean Health System to cope with this phenomenon. Dr. Anríquez will expose the real burden of MM on health services at all levels and expose new tools for population risk stratification based on MM. Paula Zamorano will focus on value- based care model to manage MM, as she will expose an innovative MM model been carried by her team at the Center of Health Innovation-PUC. Dr. Abel Castaño will address Colombia´s actual state regarding multimorbidity and its financial burden to the system, as well as innovations on health in the Colombian scenario.